Fenoldopam mesilate or mesylate

This classification denotes a dopamine agonist with the molecular formula C16H16ClNO3.CH4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HA3R0MY016, chemically known as 1h-3-benzazepine-7,8-diol, 6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-, methanesulfonate (salt), but more generally known as fenoldopam mesylate, which bears US NIH Compound Identifier 3341. European Medicines Agency schedules fenoldopam mesylate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07577MIG. Most nations, for tariff purposes, schedule fenoldopam mesylate under HS 29339930. As of Q4 2014, FENOLDOPAM MESYLATE remains US FDA's Preferred Term for this commodity. Fenoldopam mesylate bears US NLM identifiers UMLS ID C0700481 and NCI Concept Code C47531. SMILES: CS(=O)(=O)O.C1CC(CCC1C2CNCCC3C2CC(C(C3CL)O)O)O.